Parameter | Time | Control group | Treated group |
---|---|---|---|
 | 7d | 2.5 ± 1.1 | 2.9 ± 1.8 |
Lesion reduction (%) | 21d | 31.8 ± 10.6 | 36.4 ± 9.8 |
 | 35d | 44.5 ± 11.8 | 49.8 ± 13.7 |
 | 7d | 23.4 ± 6.9 | 33.2 ± 7.8* p=0,048 |
Fibroblastic cells | 21d | 47.4 ± 7.3 | 60.6 ± 8.1* p=0,041 |
(n/104 μm2) | 35d | 91.5 ± 12.8 | 107.8 ± 10.7* p=0,036 |
 | 7d | 37.4 ± 5.9 | 84.2 ± 9.8* p=0,021 |
Granulocytes | 21d | 38.4 ± 7.3 | 54.6 ± 8.1* p=0,042 |
(n/104 μm2) | 35d | 18.5 ± 3.8 | 19.8 ± 4.7 |
 | 7d | 47.4 ± 11.9 | 44.2 ± 9.8 |
Birefringent collagen fibers | 21d | 48.4 ± 9.3 | 47.6 ± 8.1 |
(%) | 35d | 87.5 ± 7.8 | 69.3 ± 9.7* p=0,045 |
 | 7d | 39.4 ± 10.9 | 41.2 ± 12.1 |
Collagen fibril diameter | 21d | 40.4 ± 12.3 | 41.6 ± 12.6 |
(nm) | 35d | 40.9 ± 11.8 | 42.3 ± 13.7 |
 | 7d | 3.4 ± 1.9 | 4.2 ± 1.1 |
Stained proteoglycans | 21d | 4.1 ± 1.7 | 7.6 ± 2.2* p=0,037 |
(n/25 μm2) | 35d | 9.9 ± 2.8 | 14.2 ± 1.7* p=0,039 |